FDA Approves First New Major Depression Drug in Decades

The U.S. Food and Drug Administration this week approved a rapid-acting antidepressant nasal spray. Spravato (esketamine), in conjunction with an oral antidepressant, is targeted at adults with major depressive disorder who have not […]

The post FDA Approves First New Major Depression Drug in Decades appeared first on Geek.com.

Source: science

Add a Comment

Your email address will not be published. Required fields are marked *